Premium
Medication‐assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation
Author(s) -
Gordon Michael S.,
Kinlock Timothy W.,
Miller Patrice M.
Publication year - 2011
Publication title -
behavioral sciences and the law
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 74
eISSN - 1099-0798
pISSN - 0735-3936
DOI - 10.1002/bsl.1015
Subject(s) - criminal justice , buprenorphine , methadone , heroin , criminology , psychological intervention , substance abuse , economic justice , psychiatry , recidivism , addiction , psychology , political science , medicine , law , drug , opioid , receptor
Creating, implementing and evaluating substance abuse interventions, especially medication‐assisted treatments, for prisoners, parolees, and probationers with histories of heroin addiction is an especially challenging endeavor because of the difficulty in coordinating and achieving cooperation among diverse criminal justice, substance abuse treatment, research, and social service agencies, each with its own priorities and agenda. In addition, there are special rules that must be followed when conducting research with criminal justice‐involved populations, particularly prisoners. The following case studies will explore the authors' experience of over 10 years conducting pharmacotherapy research using methadone, buprenorphine, and naltrexone with criminal justice populations. The major obstacles and how they were overcome are presented. Finally, recommendations are provided with regard to implementing and conducting research with criminal justice populations. Copyright © 2011 John Wiley & Sons, Ltd.